We have previously demonstrated that NRP-1 acts as a multiple co-receptor to promote the proliferation of cancer cells by activating the VEGF/VEGFR2 (VEGF receptor 2), EGF/EGFR (EGF receptor) and HGF/c-Met pathways [9, 10]. Here, NRP1 is linked to cancer.